Sergio Chimenti

Immunology and Microbiology · Life Sciences

53h-index13.7kcitations287works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(132), Dermatology and Skin Diseases(63), Cutaneous lymphoproliferative disorders research(40), Cutaneous Melanoma Detection and Management(35), Nonmelanoma Skin Cancer Studies(28)

Publications286 total

Il fascino della luce naturale
Abitare·2018
Eruptive xanthomas and pancretitis: clinical, dermatoscopy, confocal and pathological correlation
Italian Journal of Dermatology and Venereology·2017· 2 cited
New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?
Italian Journal of Dermatology and Venereology·2017· 6 cited
Granuloma annulare: a case treated with infliximab successfully
Italian Journal of Dermatology and Venereology·2017· 3 cited
The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis
Oncotarget·2017· 18 citedOpen Access
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis
Journal of Dermatological Treatment·2016· 19 cited
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.
PubMed·2016· 6 cited
Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice
Journal of International Medical Research·2016· 9 citedOpen Access
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience
Journal of International Medical Research·2016· 6 citedOpen Access
Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study
Journal of International Medical Research·2016· 11 citedOpen Access
469 Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells
Journal of Investigative Dermatology·2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis
Journal of the European Academy of Dermatology and Venereology·2016· 16 cited
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis
Expert Opinion on Drug Metabolism & Toxicology·2016· 19 citedOpen Access
Real‐life 9‐year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single‐centre, retrospective study
Journal of the European Academy of Dermatology and Venereology·2016· 37 cited
Tofacitinib for the treatment of psoriasis
Expert Opinion on Pharmacotherapy·2016· 29 cited
Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015)
Expert Opinion on Therapeutic Patents·2016· 21 citedOpen Access
031 Experimental therapeutic melanoma vaccination by ECP-generated dendritic cells
Journal of Investigative Dermatology·2016
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study
Current Medical Research and Opinion·2016· 33 cited
HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis
Molecular Diagnosis & Therapy·2016· 9 cited
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports
Journal of Medical Case Reports·2016· 7 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

H. Peter Soyer(10), Giuseppe Argenziano(8), Ketty Peris(7), Andrea Chiricozzi(7), Antonio Costanzo(7), Rosita Saraceno(7), Domenico Piccolo(6), Renato Talamini(5), Gaetano De Rosa(4), Alan Menter(4), Kim Papp(4), Alessandro Giunta(4), C.E.M. Griffiths(4), Maria Esposito(4), Laura Diluvio(4), Caterina Schipani(4), Luca Bianchi(4), Rosamaria Corona(3), Francesco Sera(3), Gerardo Ferrara(3)